Search Within

Anton Safonov

Formats
  1. Meeting Abstract (20)
  2. Journal Article (16)
Groups
  1. GME, Medicine (36)
  2. Graduate Medical Education (36)
  3. Hematology-Oncology Fellows (36)
  4. Weinberg Fellows (36)
  5. Breast Medicine Service (35)
  6. Department of Medicine (35)

More Groups

People
  1. Pedram Razavi (30)
  2. Sarat Chandarlapaty (18)
  3. Mark Robson (13)
  4. Jorge Reis-Filho (12)
  5. Larry Norton (11)
  6. Emanuela Ferraro (9)

More People

Years
  1. 2025 (9)
  2. 2024 (14)
  3. 2023 (4)
  4. 2022 (6)
  5. 2021 (2)
  6. 2020 (1)
Publications
  1. Journal of Clinical Oncology (16)
  2. Nature Communications (3)
  3. Annals of Oncology (2)
  4. Cancer Research (2)
  5. Cell (2)
  6. Blood (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. Nature Publishing Group (6)
  3. Cell Press (4)
  4. American Association for Cancer Research (3)
  5. Oxford University Press (2)
  6. American Society of Hematology (1)

More Publishers

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive (HR+) metastatic breast cancer
    Meeting Abstract

    Shen, S.; Safonov, A.; Bromberg, M.; Chen, Y.; Ahmed, M.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer
    Journal Article

    Tai, Y.; Chow, A.; Han, S.; Coker, C.; Ma, W.; Gu, Y.; Estrada Navarro, V.; Kandpal, M.; Hibshoosh, H.; Kalinsky, K.; more...
    EMBO Molecular Medicine (2024)

    Fulltext@MSK | Save
  • Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
    Journal Article

    Chew, S. M.; Ferraro, E.; Safonov, A.; Chen, Y.; Kelly, D.; Razavi, P.; Robson, M.; Seidman, A. D.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer
    Journal Article

    Kim, S.; Armand, J.; Safonov, A.; Zhang, M.; Soni, R. K.; Schwartz, G.; McGuinness, J. E.; Hibshoosh, H.; Razavi, P.; Kim, M.; more...
    Cell Reports (2023)

    Fulltext@MSK | Save
  • Large-scale clinicogenomic models of solid tumor CNS metastasis
    Meeting Abstract

    Jee, J.; Luthra, A.; Fong, C.; Pichotta, K.; Tran, T.; Altoe, M.; Miller, A.; Shen, R.; Berger, M. F.; Sanchez-Vega, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world (RW) outcomes of patients (pts) with advanced breast cancer (aBC) with and without resistance alterations (alts) detected in cell-free circulating tumor DNA (ctDNA) prior to CDK4/6 inhibitor (CDK4/6i) plus endocrine therapy (ET) treatment
    Meeting Abstract

    Wander, S. A.; Weipert, C. M.; Liao, J.; Safonov, A.; Zhang, N.; Bardia, A.; Razavi, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Marra, A.; Gazzo, A.; Gupta, A.; Selenica, P.; Da Silva, E. M.; Pareja, F.; Pei, X.; Zhu, Y.; Razavi, P.; Safonov, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on tumor control following radiation therapy
    Meeting Abstract

    Tao, J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save